BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX)
| Fund Assets | 6.47B |
| Expense Ratio | 1.09% |
| Min. Investment | $1,000 |
| Turnover | 43.00% |
| Dividend (ttm) | 6.88 |
| Dividend Yield | 10.02% |
| Dividend Growth | 20.05% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 9, 2025 |
| Previous Close | 68.21 |
| YTD Return | 0.53% |
| 1-Year Return | 8.97% |
| 5-Year Return | 24.46% |
| 52-Week Low | 55.66 |
| 52-Week High | 70.34 |
| Beta (5Y) | n/a |
| Holdings | 161 |
| Inception Date | Dec 21, 1999 |
About SHSAX
BlackRock Health Sciences Opportunities Fund, Investor A is a mutual fund focused on delivering long-term capital growth by investing primarily in equities within the health sciences sector. It allocates at least 80% of its assets to common stocks of companies engaged in healthcare and related industries, including health care equipment and supplies, biotechnology, pharmaceuticals, and health care providers and services. The fund emphasizes innovation and scientific expertise in its investment approach, offering diversified exposure to both domestic and non-U.S. companies in the healthcare field. With a portfolio that balances growth potential and risk management, it targets diversified returns with lower volatility. The fund is noted for its broad coverage across large-cap health sciences companies, holding around 145 stocks, and has received a Morningstar Bronze Medal for its risk-adjusted performance. Its position within the health sector makes it a significant vehicle for investors seeking concentrated exposure to innovative healthcare equities while benefiting from BlackRock’s investment management capabilities.
Performance
SHSAX had a total return of 8.97% in the past year, including dividends. Since the fund's inception, the average annual return has been 19.73%.
Top 10 Holdings
47.30% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.14% |
| Johnson & Johnson | JNJ | 8.58% |
| AbbVie Inc. | ABBV | 4.08% |
| Abbott Laboratories | ABT | 4.00% |
| UnitedHealth Group Incorporated | UNH | 3.67% |
| Merck & Co., Inc. | MRK | 3.65% |
| Gilead Sciences, Inc. | GILD | 3.29% |
| Medtronic plc | MDT | 3.14% |
| Amgen Inc. | AMGN | 2.97% |
| Intuitive Surgical, Inc. | ISRG | 2.79% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2025 | $3.04694 | Dec 10, 2025 |
| Jul 17, 2025 | $3.83665 | Jul 18, 2025 |
| Dec 11, 2024 | $3.2425 | Dec 12, 2024 |
| Jul 18, 2024 | $2.49135 | Jul 19, 2024 |
| Dec 7, 2023 | $1.17094 | Dec 8, 2023 |
| Jul 20, 2023 | $1.34151 | Jul 21, 2023 |